Sciomics: Enabling precision medicine -

@
  • Home
  • Protein & PTM analysis
    • scioDiscover
      Protein Expression Analysis
      • Protein Profiling
      • Protein Biomarker Discovery
      • Drug Target Discovery
      • Array content
      • Quality Assurance
      • scioDiscover - Features and Advantages
    • scioPhospho
      Phosphorylation + Protein Profiling
    • scioUbi
      Protein + ubiquitination profiling
      • scioUbi case study
    • scioCD
      cell surface marker + cytokine profiling
    • scioCyto
      Cytokine profiling
  • What our customers say
  • About us
    • Register for our newsletter
    • What our customers say
    • Scientific articles & patents
    • Press releases
    • Your career at Sciomics
    • Our Partners & Networks
    • Contact us
  • Contact us

BioJapan 2023

Meet us at BioJapan 2023 in Yokohama

Beadcrumbs

  • Protein & PTM analysis /
  • scioDiscover /
  • Quality Assurance
  • / en

Subcategories

  • Home
  • company
  • Applications
  • products and services
  • News
  • Events
  • SpecNews
  • Testimonials
  • Corona

Our service portfolio

scioPhospho: protein profiling and phosphorylation status

scioPhospho: protein profiling and phosphorylation status

scioPhospho combines the advantages of a robust and cost-efficient protein expression profiling using scioDiscover with information on phosphorylation status. This combination provides a comprehensive overview on signalling events and pathway activity regulation. Features 1,300 highly relevant proteins are profiled in a single assay Phosphorylation status combined with protein expression levels…
Read more
scioDiscover - Protein Profiling on expression level

scioDiscover - Protein Profiling on expression level

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised…
scioCD - Cell surface marker and Cytokine profiling

scioCD - Cell surface marker and Cytokine profiling

  Characterise a certain cell type?   Cell composition in a certain tissue sample?   In-depth profiling of CD-marker expression?   Increase your throughput at high sensitivity levels? You aim…
scioUbi

scioUbi

Protein & ubiquitination profiling scioUbi is a high-content protein expression and ubiquitination level analysis. With scioUbi you can analyse up to 1,000 proteins in a single assay.   Features Screen…
scioCyto : Cytokine profiling

scioCyto : Cytokine profiling

scioCyto : Cytokine profiling scioCyto is a high-content analysis service for multiplex cytokine and chemokine profiling on protein level. A great variety of samples such as plasma, tissue, cells or…

COVID-19 related activities and services

covid 19 portfolio web

News

New article | Rapid Diagnostic Platform for Personalized Vitamin B6 Detection in Erythrocytes

| July 2023 | New Article: Fiedler et al. developed a novel methodology for vitamin B6 diagnostics. We supported the project by the production of custom antibody microarray targeting signature human PLP-DE and testing respective samples.

Fiedler et al. Rapid Diagnostic Platform for Personalized Vitamin B6 Detection in Erythrocytes via PLP Cofactor Mimics (2023) ACS Chem Biol.
New article | Biomarkers for canine mammary neoplasia

| Mai 2023 | New Article: Galadima et al. used the scioCD assay to analyse canine blood samples in the context of mammary neoplasia. The proteins CD20, CD45RA and CD99 were found at altered levels. The findings were validated by Western Blotting and are suggested as novel serum biomarkers.

Galadima et al. Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99 (2023) Int. J. Mol. Sci. 24(11)
New article | Microbiota influences chemotherapy in pancreatic cancer

| February 2023 | New Article: In the study Tintelnot et al. identified a microbiota-derived metabolite that has clinical implications in the treatment of pancreatic cancer. Sciomics supported the authors by a protein profiling study of tumours derived from a mouse model upon treatment with 3-IAA and Firinox.

Tintelnot et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615, 168-174 (2023)
New article | HAPLN1 potentiates peritoneal metastasis in pancreatic cancer

| April 2023 | New Article: Wiedmann et al. identified HAPLN1 as a prognostic marker and as a and as a driver for peritoneal metastasis in pancreatic cancer. Sciomics contributed a plasma protein profiling of a mouse model to support this exciting study.

Wiedmann L et al. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. Nature Communications 14,2354 (2023)
New article | Predicting a severe Covid-19 disease

| April 2023 | New Article: In a protein biomarker development project initiated by Sciomics, we have identified protein biomarker panels predicting development of a severe Covid.19  disease.

Hufnagel K., Fathi A. et al. Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease. Communications Medicine 3,51 (2023)

Testimonials

Dr. Matthew Wright

Chief Scientific Officer, Kinarus Therapeutics AG, Basel, Switzerland

"We are a small biotech company without our own wet labs. Sciomics recommended a UK CRO that performed cell culture experiments for our studies. Sciomics seamlessly coordinated the transfer of the biologic materials to their facility and performed the scioCD panel to characterize cell surface markers and cytokines in cell lines treated with our small molecule drug candidates. The Sciomics data were instrumental in supporting our IP protection strategy. Their advice was very helpful and they worked with us to extract the most out of the data. We are very satisfied and highly recommend the Sciomics platform and the team."

Product: scioCD

Kyriaki Barmpa

PhD Candidate, Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

"By collaborating with Sciomics, we conducted a detailed analysis of the proteome of striatum organoids, uncovering significant differences that further assisted our research. Their communication was highly efficient, and the results were delivered promptly."

Product: scioPhospho

Tweets

  • over a year ago

Newsletter

Subscribe to our newsletter to keep updated on our product and service portfolio.
 

Subscribe

Contact

  This email address is being protected from spambots. You need JavaScript enabled to view it.
  +49 6221 4294830

 Contact us

BMBF-funding

Sponsored by the Federal Ministry of Education and Research (BmBF), GermanyInnovative through Research

Legal

Copyright © 2013-2021 Sciomics GmbH, All rights reserved.

Imprint / Impressum     Data Privacy Policy / Datenschutzerklärung

BACK_TO_TOP
  • Home
  • Protein & PTM analysis
    • scioDiscover
      Protein Expression Analysis
      • Protein Profiling
      • Protein Biomarker Discovery
      • Drug Target Discovery
      • Array content
      • Quality Assurance
      • scioDiscover - Features and Advantages
    • scioPhospho
      Phosphorylation + Protein Profiling
    • scioUbi
      Protein + ubiquitination profiling
      • scioUbi case study
    • scioCD
      cell surface marker + cytokine profiling
    • scioCyto
      Cytokine profiling
  • What our customers say
  • About us
    • Register for our newsletter
    • What our customers say
    • Scientific articles & patents
    • Press releases
    • Your career at Sciomics
    • Our Partners & Networks
    • Contact us
  • Contact us